Puma Biotechnology Inc
NASDAQ:PBYI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
US |
|
S
|
SAP SE
XMUN:SAP
|
DE |
|
Titan International Inc
NYSE:TWI
|
US |
|
T
|
Thales SA
XMUN:CSF
|
FR |
|
A
|
Allianz SE
XBER:ALV
|
DE |
|
C
|
Cummins Inc
XBER:CUM
|
US |
|
M
|
Microchip Technology Inc
XETRA:MCP
|
US |
|
D
|
Deere & Co
F:DCO
|
US |
|
B
|
Barito Pacific Tbk PT
XMUN:OB8
|
ID |
|
C
|
Currys PLC
DUS:CWB
|
UK |
|
Tenet Healthcare Corp
NYSE:THC
|
US |
|
Comfort Systems USA Inc
NYSE:FIX
|
US |
|
A
|
Allianz SE
XMUN:ALV
|
DE |
|
Bajaj Finance Ltd
NSE:BAJFINANCE
|
IN |
Wall St Price Targets
PBYI Price Targets Summary
Puma Biotechnology Inc
According to Wall Street analysts, the average 1-year price target for PBYI is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PBYI's stock price target?
Price Target
5.1
USD
According to Wall Street analysts, the average 1-year price target for PBYI is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.
What is the Revenue forecast for Puma Biotechnology Inc?
Projected CAGR
-1%
The compound annual growth rate for Revenue over the next 5 years is -1%.
What is the Operating Income forecast for Puma Biotechnology Inc?
Projected CAGR
-19%
The compound annual growth rate for Operating Income over the next 5 years is -19%.
What is the Net Income forecast for Puma Biotechnology Inc?
Projected CAGR
-10%
The compound annual growth rate for Net Income over the next 5 years is -10%.
